MacroGenics, Inc. (MGNX)
2.23
+0.09
(+4.21%)
USD |
NASDAQ |
Mar 06, 16:00
2.245
+0.02
(+0.67%)
After-Hours: 20:00
MacroGenics Cash from Investing (TTM) : -6.64M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Amgen, Inc. | -1.943B |
| Amicus Therapeutics, Inc. | -46.43M |
| Merck & Co., Inc. | -13.74B |
| CorMedix, Inc. | -308.43M |
| Xencor, Inc. | 139.98M |